Last reviewed · How we verify
Nitroglycerin ointment 2%, USP — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Nitroglycerin ointment 2%, USP (Nitroglycerin ointment 2%, USP) — MediQuest Therapeutics.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Nitroglycerin ointment 2%, USP TARGET | Nitroglycerin ointment 2%, USP | MediQuest Therapeutics | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Nitroglycerin ointment 2%, USP CI watch — RSS
- Nitroglycerin ointment 2%, USP CI watch — Atom
- Nitroglycerin ointment 2%, USP CI watch — JSON
- Nitroglycerin ointment 2%, USP alone — RSS
Cite this brief
Drug Landscape (2026). Nitroglycerin ointment 2%, USP — Competitive Intelligence Brief. https://druglandscape.com/ci/nitroglycerin-ointment-2-usp. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing